QT - Parkinsonism
Codelist metadata
- Coding system
- SNOMED CT (UK Clinical Edition)
- Coding system release
- 35.2.0
- Author
- Tom Nichols
- Codelist ID
- user/tom-nichols/qt-parkinsonism
- Version ID
- 01139dac
- Number of codes included
- 152
About
No metadata has been provided for this codelist.
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
| code | term |
|---|---|
| 1010642001 | Sporadic infantile bilateral striatal necrosis |
| 101421000119107 | Dementia due to Parkinson's disease |
| 102448004 | Drug-induced dyskinesia |
| 102449007 | Tardive dyskinesia |
| 1032661000000100 | Multiple system atrophy, Parkinson variant |
| 1032671000000107 | Multiple system atrophy, Parkinson variant |
| 103871000119109 | Restrictive lung disease due to Parkinson disease |
| 1156764005 | Progressive supranuclear palsy parkinsonism syndrome |
| 1156822001 | Autosomal recessive familial Parkinson disease |
| 1176989007 | Parkinsonism due to prion disease |
| 1176991004 | Parkinsonism following Mycoplasma infection |
| 1186798007 | Parkinsonism caused by pesticide |
| 1186836002 | Parkinsonism caused by toxin |
| 1208478005 | Familial infantile bilateral striatal necrosis |
| 1230018005 | Corticobasal syndrome |
| 1230308005 | Off-periods in Parkinson disease not responding to oral treatment |
| 135811000119107 | Lewy body dementia with behavioral disturbance |
| 140876005 | O/E - Parkinsonian tremor |
| 140885005 | O/E -Parkinson flexion posture |
| 140891007 | O/E - festination (& [Parkinson gait]) |
| 15244003 | Neuroleptic malignant syndrome |
| 154999006 | Parkinson's disease |
| 155000006 | Parkinson's disease |
| 155001005 | Drug-induced parkinsonism |
| 155002003 | Parkinson's disease NOS |
| 15755701000119105 | Fluency disorder due to Parkinson disease |
| 15782007 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism |
| 161106009 | Parkinson's Society member |
| 16270221000119108 | Acute akathisia caused by drug |
| 163672003 | On examination - Parkinsonian tremor |
| 163681009 | On examination - Parkinson flexion posture |
| 163687008 | O/E - festination (& [Parkinson gait]) |
| 192177005 | [X]Dementia in Parkinson's disease |
| 192808003 | Lewy body disease |
| 192825001 | Parkinson's disease |
| 192828004 | Postencephalitic parkinsonism |
| 192829007 | [X]Secondary parkinsonism due to other external agents |
| 192830002 | [X]Secondary parkinsonism, unspecified |
| 192831003 | Parkinson's disease NOS |
| 192832005 | Extrapyramidal disease: [excluding Parkinson's disease] or [other and abnormal movement disorders] |
| 192835007 | Parkinsonism with orthostatic hypotension |
| 194468007 | [X]Other drug-induced secondary parkinsonism |
| 194469004 | [X]Other secondary parkinsonism |
| 194470003 | [X]Parkinsonism in diseases classified elsewhere |
| 194477000 | [X]Secondary parkinsonism, unspecified |
| 194479002 | [X]Secondary parkinsonism due to other external agents |
| 198681000000106 | [X]Lewy body dementia |
| 19972008 | Postencephalitic parkinsonism |
| 214031000000108 | [X]Lewy body dementia |
| 22719003 | Acute akathisia caused by neuroleptic |
| 230275004 | Lewy body disease |
| 230276003 | Lewy body disease |
| 230277007 | Lewy body disease |
| 230291001 | Juvenile Parkinson's disease |
| 230292008 | Secondary parkinsonism |
| 230293003 | Carbon monoxide-induced parkinsonism |
| 230294009 | Manganese-induced parkinsonism |
| 230295005 | Parkinsonism with calcification of basal ganglia |
| 230296006 | Vascular parkinsonism |
| 230315008 | Drug-induced dystonia |
| 230316009 | Drug-induced acute dystonia |
| 230317000 | Drug-induced tardive dystonia |
| 230333002 | Akathisia caused by drug |
| 230334008 | Tic caused by drug |
| 230346007 | Drug-induced myoclonus |
| 248208000 | Parkinsonian facies |
| 250036006 | Extrapyramidal gait |
| 250053004 | Parkinsonian ataxia |
| 265377002 | Symptomatic parkinsonism |
| 26823002 | Parkinson's facies |
| 268964003 | On examination - festination-Parkinson gait |
| 271704002 | Parkinsonian flexion posture |
| 29618004 | Striatonigral degeneration |
| 300993007 | Drug-induced orofacial dyskinesia |
| 304535004 | Parkinsonian features |
| 308909003 | Parkinsonian tremor |
| 312991009 | Senile dementia of the Lewy body type |
| 31430005 | Medication-induced postural tremor |
| 32798002 | Parkinsonism |
| 341551000000108 | Cerebral degeneration in Parkinson's disease |
| 368771000000107 | Cerebral degeneration in Parkinson's disease |
| 38523005 | Syphilitic parkinsonism |
| 38941006 | Neuroleptic-induced tardive dyskinesia |
| 390141000000101 | [X]Secondary parkinsonism due to other external agents |
| 394962002 | Parkinsonism |
| 396511000000105 | [X]Other drug-induced secondary parkinsonism |
| 412431000000109 | [X]Secondary parkinsonism due to other external agents |
| 4223005 | Parkinsonism caused by drug |
| 425390006 | Dementia associated with Parkinson's Disease |
| 427488005 | On - off phenomenon |
| 42769004 | Diffuse Lewy body disease with spongiform cortical change |
| 438513002 | Cerebral degeneration due to Parkinson's disease |
| 444197004 | Multiple system atrophy, Parkinson variant |
| 456481000000104 | [X]Secondary parkinsonism, unspecified |
| 471011000000107 | [X]Secondary parkinsonism, unspecified |
| 47362003 | Medication-induced movement disorder |
| 477761000000101 | [X]Other secondary parkinsonism |
| 477771000000108 | [X]Parkinsonism in diseases classified elsewhere |
| 479161000000109 | [X]Dementia in Parkinson's disease |
| 49049000 | Parkinson's disease |
| 50364008 | Secondary parkinsonism |
| 51100001 | Hypokinetic parkinsonian dysphonia |
| 515841000000104 | History of Parkinson's disease |
| 515851000000101 | History of parkinsonism |
| 604451000000109 | Parkinson's disease NOS |
| 62239001 | Parkinson-dementia complex of Guam |
| 698279003 | X-linked dystonia parkinsonism |
| 699184009 | Perry syndrome |
| 702323008 | Rapid onset dystonia parkinsonism |
| 702429008 | Frontotemporal dementia with parkinsonism-17 |
| 707791000000105 | Vascular parkinsonism |
| 715345007 | Young onset Parkinson disease |
| 715737004 | Parkinsonism co-occurrent with dementia of Guadeloupe |
| 716107009 | Early onset parkinsonism and intellectual disability syndrome |
| 716662004 | Autosomal dominant late onset Parkinson disease |
| 718174008 | Infantile striatonigral degeneration |
| 718685006 | Orthostatic hypotension co-occurrent and due to Parkinson's disease |
| 719717006 | Psychosis co-occurrent and due to Parkinson's disease |
| 720466001 | Adult-onset dystonia parkinsonism |
| 722435003 | Dystonia 16 |
| 722556003 | Parkinsonism co-occurrent and due to acute infection |
| 722557007 | Parkinsonism due to human immunodeficiency virus infection |
| 722558002 | Parkinsonism following infection |
| 722599008 | Parkinsonism due to hereditary spastic paraplegia |
| 722763000 | Infantile dystonia parkinsonism |
| 722964001 | Atypical Parkinsonism |
| 722965000 | Parkinsonism due to heredodegenerative disorder |
| 723992000 | Kufor Rakeb syndrome |
| 724546003 | Infection causing parkinsonism |
| 724761004 | Sporadic Parkinson disease |
| 724762006 | Parkinsonism due to and following injury of head |
| 724763001 | Parkinsonism due to mass lesion of brain |
| 724823008 | Functional parkinsonism |
| 725146001 | Atypical juvenile parkinsonism |
| 725392005 | Autosomal dominant striatal neurodegeneration |
| 72585000 | Parkinsonian syndrome with idiopathic orthostatic hypotension |
| 72820004 | Parkinsonism caused by neuroleptic drug |
| 737582007 | Hemiparkinsonism hemiatrophy syndrome |
| 756881000000108 | History of Parkinson's disease |
| 766872002 | Parkinsonism caused by cyanide |
| 770757004 | X-linked parkinsonism with spasticity syndrome |
| 783012006 | Parkinsonian pyramidal syndrome |
| 788911004 | Dissociative neurological symptom disorder co-occurrent with Parkinsonism |
| 789046004 | Sleep-related movement disorder caused by drug |
| 789657008 | ATPase cation transporting 13A2 related juvenile neuronal ceroid lipofuscinosis |
| 80098002 | Diffuse Lewy body disease |
| 83465002 | Neuroleptic-induced acute dystonia |
| 838276009 | Amyotrophic lateral sclerosis, parkinsonism, dementia complex |
| 870288002 | Parkinsonism caused by methanol |
| 870295006 | Parkinsonism caused by carbon disulfide |
| 93433003 | Drug-induced dyskinesia, acute onset |
| 98811000119103 | Subacute dyskinesia caused by drug |
This page shows the search terms that were used to build the codelist. Concepts that match the search terms, but which were excluded, are in faint grey.
Medication-induced movement disorder
Included 23 out of 23 matching concepts.
Show matching concepts
-
Acute akathisia caused by drug (
16270221000119108) -
Acute akathisia caused by neuroleptic (
22719003) -
Akathisia caused by drug (
230333002) -
Drug-induced acute dystonia (
230316009) -
Drug-induced dyskinesia (
102448004) -
Drug-induced dyskinesia, acute onset (
93433003) -
Drug-induced dystonia (
230315008) -
Drug-induced myoclonus (
230346007) -
Drug-induced orofacial dyskinesia (
300993007) -
Drug-induced tardive dystonia (
230317000) -
Medication-induced movement disorder (
47362003) -
Medication-induced postural tremor (
31430005) -
Neuroleptic malignant syndrome (
15244003) -
Neuroleptic-induced acute dystonia (
83465002) -
Neuroleptic-induced tardive dyskinesia (
38941006) -
On - off phenomenon (
427488005) -
Parkinsonism caused by drug (
4223005) -
Parkinsonism caused by methanol (
870288002) -
Parkinsonism caused by neuroleptic drug (
72820004) -
Sleep-related movement disorder caused by drug (
789046004) -
Subacute dyskinesia caused by drug (
98811000119103) -
Tardive dyskinesia (
102449007) -
Tic caused by drug (
230334008)
lewy
Included 10 out of 11 matching concepts.
Show matching concepts
-
Diffuse Lewy body disease (
80098002) -
Diffuse Lewy body disease with spongiform cortical change (
42769004) -
Lewy bodies (
43127003) -
Lewy body dementia with behavioral disturbance (
135811000119107) -
Lewy body disease (
192808003) -
Lewy body disease (
230277007) -
Lewy body disease (
230275004) -
Lewy body disease (
230276003) -
Senile dementia of the Lewy body type (
312991009) -
[X]Lewy body dementia (
198681000000106) -
[X]Lewy body dementia (
214031000000108)
parkinson
Included 123 out of 569 matching concepts.
Show matching concepts
-
(Anomalous A-V excitation) or (Wolff-Parkinson-White syndrome) (
155360000) -
(Anomalous A-V excitation) or (Wolff-Parkinson-White syndrome) (
266304003) -
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism (
15782007) -
ATPase cation transporting 13A2 related juvenile neuronal ceroid lipofuscinosis (
789657008) -
Accidental poisoning by anticonvulsant &/or anti-parkinsonism drug (
216568004) -
Accidental poisoning by anticonvulsant and antiparkinsonism drugs NOS (
672981000000108) -
Accidental poisoning by anticonvulsant and antiparkinsonism drugs NOS (
216574004) -
Accidental poisoning caused by anticonvulsant and antiparkinsonism drugs (
269689002) -
Adult-onset dystonia parkinsonism (
720466001) -
Adverse reaction caused by antiparkinsonism drug (
430136001) -
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS (
218659003) -
Adverse reaction to anticonvulsant and antiparkinsonism drugs NOS (
686151000000107) -
Adverse reaction to anticonvulsants and anti-parkinsonism drugs (
218633001) -
Adverse reaction to antiparkinsonism drug (
218651000) -
Adverse reaction to antiparkinsonism drugs NOS (
218658006) -
Adverse reaction to antiparkinsonism drugs NOS (
686141000000109) -
Adverse reaction to carbidopa and/or levodopa (
876800006) -
Amantadine (
372763006) -
Amantadine adverse reaction (
292269000) -
Amantadine hydrochloride (
64507008) -
Amantadine sulfate (
703084004) -
Amantidine hydrochloride [parkinsons] (
323127009) -
Amyotrophic lateral sclerosis, parkinsonism, dementia complex (
838276009) -
Anticonvulsant and antiParkinsonian drug poisoning (
269265001) -
Anticonvulsant or antiparkinsonian drug (
312055000) -
Anticonvulsant or antiparkinsonian drug poisoning NOS (
575971000000105) -
Anticonvulsant or antiparkinsonian drug poisoning NOS (
212627004) -
Antimuscarinic agent used in parkinsonism (
373243006) -
Antimuscarinic drug used in parkinsonism (
358925002) -
Antiparkinson therapeutic role (
773881003) -
Antiparkinsonian agent (
372783007) -
Antiparkinsonian drug poisoning NOS (
212626008) -
Antiparkinsonian drug poisoning NOS (
575961000000103) -
Apomorphine (
387375001) -
Apomorphine adverse reaction (
292270004) -
Apomorphine hydrochloride (
74950007) -
Apomorphine hydrochloride hemihydrate (
725667002) -
Assessment using Lindop Parkinson's assessment scale (
845411000000105) -
Assessment using Penn Parkinson's Daily Activities Questionnaire-15 (
725844001) -
Assessment using Penn Parkinson's Daily Activities Questionnaire-15 (
1061351000000105) -
Assessment using Unified Parkinson's Disease Rating Scale (
1099211000000102) -
Atypical Parkinsonism (
722964001) -
Atypical juvenile parkinsonism (
725146001) -
Autosomal dominant late onset Parkinson disease (
716662004) -
Autosomal dominant striatal neurodegeneration (
725392005) -
Autosomal recessive familial Parkinson disease (
1156822001) -
Benserazide (
391821005) -
Benserazide hydrochloride (
391822003) -
Benzatropine (
372846002) -
Benzatropine 1mg tablets (
376816002) -
Benzatropine mesilate (
29527005) -
Benzhexol adverse reaction (
292535000) -
Benztropine adverse reaction (
292536004) -
Biperiden (
387359004) -
Biperiden adverse reaction (
292527003) -
Biperiden hydrochloride (
10020007) -
Biperiden lactate (
61742009) -
Bromocriptine (
387039007) -
Bromocriptine [parkinsons] (
323134006) -
Bromocriptine adverse reaction (
292274008) -
Bromocriptine mesilate (
46293006) -
Cabergoline (
386979007) -
Cabergoline [parkinsons] (
323191001) -
Cabergoline adverse reaction (
293262002) -
Carbidopa (
73579000) -
Carbidopa anhydrous (
785688002) -
Carbidopa monohydrate (
725789008) -
Carbon monoxide-induced parkinsonism (
230293003) -
Cerebral degeneration due to Parkinson's disease (
438513002) -
Cerebral degeneration in Parkinson's disease (
341551000000108) -
Cerebral degeneration in Parkinson's disease (
368771000000107) -
Corticobasal syndrome (
1230018005) -
Cycrimine (
71108007) -
Decarboxylase inhibitor adverse reaction (
292408007) -
Dementia associated with Parkinson's Disease (
425390006) -
Dementia due to Parkinson's disease (
101421000119107) -
Dihydro-alpha-ergocryptine (
24650007) -
Dihydro-alpha-ergocryptine mesilate (
426582003) -
Dihydro-beta-ergocryptine (
75561002) -
Dihydro-beta-ergocryptine mesilate (
425819004) -
Dihydroergocryptine (
412173004) -
Dihydroergocryptine mesilate (
708572008) -
Dihydroxyphenylalanine (
65955006) -
Dissociative neurological symptom disorder co-occurrent with Parkinsonism (
788911004) -
Dopamine agonist (
108808007) -
Dopaminergic drug used in parkinsonism adverse reaction (
292265006) -
Dopaminergic drug used in parkinsonism allergy (
293807004) -
Drug-induced parkinsonism (
155001005) -
Dystonia 16 (
722435003) -
Early onset parkinsonism and intellectual disability syndrome (
716107009) -
Entacapone (
387018000) -
Extrapyramidal disease: [excluding Parkinson's disease] or [other and abnormal movement disorders] (
192832005) -
Extrapyramidal gait (
250036006) -
FH: [CNS disorder NOS] or [Parkinsonism] (
137743004) -
FH: [CNS disorder NOS] or [Parkinsonism] (
160345004) -
Familial infantile bilateral striatal necrosis (
1208478005) -
Family history of Parkinson's disease (
297240003) -
Family history: Parkinsonism (
275117004) -
Fluency disorder due to Parkinson disease (
15755701000119105) -
Frontotemporal dementia with parkinsonism-17 (
702429008) -
Functional parkinsonism (
724823008) -
Hemiparkinsonism hemiatrophy syndrome (
737582007) -
History of Parkinson's disease (
515841000000104) -
History of Parkinson's disease (
756881000000108) -
History of parkinsonism (
515851000000101) -
Hypokinetic parkinsonian dysphonia (
51100001) -
Infantile dystonia parkinsonism (
722763000) -
Infantile striatonigral degeneration (
718174008) -
Infection causing parkinsonism (
724546003) -
Istradefylline (
789546007) -
Juvenile Parkinson's disease (
230291001) -
Kufor Rakeb syndrome (
723992000) -
Levodopa (
387086006) -
Levodopa adverse reaction (
292266007) -
Lindop Parkinson's assessment scale (
844521000000102) -
Lindop Parkinson's assessment scale (
844531000000100) -
Lindop Parkinson's assessment scale score (
845421000000104) -
Lisuride (
395770007) -
Lisuride maleate (
323159002) -
Lysuride adverse reaction (
292272007) -
Manganese-induced parkinsonism (
230294009) -
Medicinal product acting as antiparkinson agent (
58050004) -
Methixene adverse reaction (
292541007) -
Metixene (
387354009) -
Metixene hydrochloride (
323245002) -
Multiple system atrophy, Parkinson variant (
1032661000000100) -
Multiple system atrophy, Parkinson variant (
444197004) -
Multiple system atrophy, Parkinson variant (
1032671000000107) -
No family history of Parkinson's disease (
932441000000109) -
No family history of Parkinson's disease (
932451000000107) -
O/E - Parkinsonian tremor (
140876005) -
O/E - festination (& [Parkinson gait]) (
163687008) -
O/E - festination (& [Parkinson gait]) (
140891007) -
O/E -Parkinson flexion posture (
140885005) -
Off-periods in Parkinson disease not responding to oral treatment (
1230308005) -
On - off phenomenon (
427488005) -
On examination - Parkinson flexion posture (
163681009) -
On examination - Parkinsonian tremor (
163672003) -
On examination - festination-Parkinson gait (
268964003) -
Opicapone (
720356008) -
Orphenadrine (
372714007) -
Orphenadrine adverse reaction (
292542000) -
Orphenadrine citrate (
387167001) -
Orphenadrine citrate adverse reaction (
292544004) -
Orphenadrine hydrochloride (
395813009) -
Orphenadrine hydrochloride adverse reaction (
292543005) -
Orthostatic hypotension co-occurrent and due to Parkinson's disease (
718685006) -
Overdose of dopaminergic drug used in parkinsonism (
295813005) -
Parkinson's Society member (
138413002) -
Parkinson's Society member (
161106009) -
Parkinson's disease (
154999006) -
Parkinson's disease (
49049000) -
Parkinson's disease (
192825001) -
Parkinson's disease (
155000006) -
Parkinson's disease NOS (
192831003) -
Parkinson's disease NOS (
155002003) -
Parkinson's disease NOS (
604451000000109) -
Parkinson's disease clinic (
702898000) -
Parkinson's disease excluded (
340761000000109) -
Parkinson's disease excluded (
369601000000104) -
Parkinson's disease excluded (
370781000000104) -
Parkinson's disease nurse (
283875005) -
Parkinson's facies (
26823002) -
Parkinson-dementia complex of Guam (
62239001) -
Parkinsonian ataxia (
250053004) -
Parkinsonian facies (
248208000) -
Parkinsonian features (
304535004) -
Parkinsonian flexion posture (
271704002) -
Parkinsonian pyramidal syndrome (
783012006) -
Parkinsonian syndrome with idiopathic orthostatic hypotension (
72585000) -
Parkinsonian tremor (
308909003) -
Parkinsonism (
394962002) -
Parkinsonism (
32798002) -
Parkinsonism caused by carbon disulfide (
870295006) -
Parkinsonism caused by cyanide (
766872002) -
Parkinsonism caused by drug (
4223005) -
Parkinsonism caused by methanol (
870288002) -
Parkinsonism caused by neuroleptic drug (
72820004) -
Parkinsonism caused by pesticide (
1186798007) -
Parkinsonism caused by toxin (
1186836002) -
Parkinsonism co-occurrent and due to acute infection (
722556003) -
Parkinsonism co-occurrent with dementia of Guadeloupe (
715737004) -
Parkinsonism due to and following injury of head (
724762006) -
Parkinsonism due to hereditary spastic paraplegia (
722599008) -
Parkinsonism due to heredodegenerative disorder (
722965000) -
Parkinsonism due to human immunodeficiency virus infection (
722557007) -
Parkinsonism due to mass lesion of brain (
724763001) -
Parkinsonism due to prion disease (
1176989007) -
Parkinsonism following Mycoplasma infection (
1176991004) -
Parkinsonism following infection (
722558002) -
Parkinsonism with calcification of basal ganglia (
230295005) -
Parkinsonism with orthostatic hypotension (
192835007) -
Parkinsonism-anticholinergics (
323211009) -
Penn Parkinson's Daily Activities Questionnaire-15 (
725843007) -
Penn Parkinson's Daily Activities Questionnaire-15 (
1061341000000107) -
Penn Parkinson's Daily Activities Questionnaire-15 total score (
1098991000000107) -
Pergolide (
372498008) -
Pergolide adverse reaction (
292273002) -
Pergolide mesilate (
108469007) -
Perry syndrome (
699184009) -
Piribedil (
713435009) -
Piribedil mesilate (
735170005) -
Poisoning caused by anti-parkinsonism drug (
4836003) -
Poisoning caused by anticonvulsant AND/OR anti-Parkinsonism drug (
105625006) -
Poisoning: [antiParkinsonian drug] &/or [anticonvulsant] (
212614003) -
Postencephalitic parkinsonism (
19972008) -
Postencephalitic parkinsonism (
192828004) -
Pramipexole (
386852009) -
Pramipexole dihydrochloride (
412282004) -
Pramipexole dihydrochloride monohydrate (
725650009) -
Procyclidine (
387247001) -
Procyclidine adverse reaction (
292547006) -
Procyclidine hydrobromide (
277019000) -
Procyclidine hydrochloride (
387199007) -
Product containing amantadine (
51361008) -
Product containing amantadine in oral dose form (
767863003) -
Product containing apomorphine in parenteral dose form (
430261009) -
Product containing benserazide (
420240007) -
Product containing benserazide and levodopa (
418467003) -
Product containing benserazide and levodopa in oral dose form (
784249002) -
Product containing benzatropine (
77390008) -
Product containing benzatropine in oral dose form (
430928009) -
Product containing benzatropine in parenteral dose form (
430262002) -
Product containing biperiden (
65041000) -
Product containing biperiden in oral dose form (
430951009) -
Product containing biperiden in parenteral dose form (
430163000) -
Product containing bromocriptine (
116656002) -
Product containing bromocriptine in oral dose form (
767943006) -
Product containing cabergoline (
109139002) -
Product containing cabergoline in oral dose form (
768044000) -
Product containing carbidopa (
386107009) -
Product containing carbidopa and entacapone and levodopa (
410860008) -
Product containing carbidopa and entacapone and levodopa in oral dose form (
768051009) -
Product containing carbidopa and levodopa (
404830004) -
Product containing carbidopa and levodopa in enteral dose form (
764375007) -
Product containing carbidopa and levodopa in oral dose form (
714558004) -
Product containing carbidopa and levodopa in oromucosal dose form (
786789005) -
Product containing carbidopa in oral dose form (
767908005) -
Product containing entacapone (
116116003) -
Product containing entacapone in oral dose form (
768142004) -
Product containing istradefylline (
789550000) -
Product containing istradefylline in oral dose form (
789552008) -
Product containing levodopa (
15383004) -
Product containing levodopa in oral dose form (
772563001) -
Product containing lisuride (
349894007) -
Product containing lisuride in oral dose form (
768352008) -
Product containing metixene (
64558005) -
Product containing only amantadine (
774525005) -
Product containing only amantadine in oral dose form (
778274004) -
Product containing only apomorphine in parenteral dose form (
778338005) -
Product containing only benserazide (
774777001) -
Product containing only benserazide and levodopa (
774778006) -
Product containing only benserazide and levodopa in oral dose form (
784250002) -
Product containing only benzatropine (
774786006) -
Product containing only benzatropine in oral dose form (
778462001) -
Product containing only benzatropine in parenteral dose form (
778463006) -
Product containing only biperiden (
774864001) -
Product containing only biperiden in oral dose form (
778521005) -
Product containing only biperiden in parenteral dose form (
778522003) -
Product containing only bromocriptine (
774919002) -
Product containing only bromocriptine in oral dose form (
778551004) -
Product containing only cabergoline (
774961008) -
Product containing only cabergoline in oral dose form (
778585003) -
Product containing only carbidopa (
775051007) -
Product containing only carbidopa and entacapone and levodopa (
775052000) -
Product containing only carbidopa and entacapone and levodopa in oral dose form (
778641006) -
Product containing only carbidopa and levodopa (
775053005) -
Product containing only carbidopa and levodopa in enteral dose form (
778642004) -
Product containing only carbidopa and levodopa in oral dose form (
778643009) -
Product containing only carbidopa and levodopa in oromucosal dose form (
786926007) -
Product containing only carbidopa in oral dose form (
778644003) -
Product containing only entacapone (
775773008) -
Product containing only entacapone in oral dose form (
779122002) -
Product containing only istradefylline (
789551001) -
Product containing only istradefylline in oral dose form (
789553003) -
Product containing only levodopa (
776515002) -
Product containing only levodopa in oral dose form (
779685001) -
Product containing only lisuride (
776553007) -
Product containing only lisuride in oral dose form (
779723003) -
Product containing only metixene (
776729003) -
Product containing only opicapone (
776994008) -
Product containing only opicapone in oral dose form (
780072004) -
Product containing only orphenadrine (
777004009) -
Product containing only orphenadrine in oral dose form (
780076001) -
Product containing only orphenadrine in parenteral dose form (
780077005) -
Product containing only pergolide (
777139007) -
Product containing only pergolide in oral dose form (
780170009) -
Product containing only piribedil (
1173978008) -
Product containing only piribedil in oral dose form (
1173980002) -
Product containing only pramipexole (
777294006) -
Product containing only pramipexole in oral dose form (
780270002) -
Product containing only procyclidine (
777323007) -
Product containing only procyclidine in oral dose form (
780296000) -
Product containing only procyclidine in parenteral dose form (
780297009) -
Product containing only rasagiline (
777401009) -
Product containing only rasagiline in oral dose form (
780349006) -
Product containing only ropinirole (
777464003) -
Product containing only ropinirole in oral dose form (
780398002) -
Product containing only rotigotine (
777472001) -
Product containing only rotigotine in transdermal dose form (
780402006) -
Product containing only safinamide (
777482000) -
Product containing only safinamide in oral dose form (
780407000) -
Product containing only selegiline in oral dose form (
780431005) -
Product containing only selegiline in oromucosal dose form (
786417003) -
Product containing only tolcapone (
777799000) -
Product containing only tolcapone in oral dose form (
780661005) -
Product containing only trihexyphenidyl (
777853005) -
Product containing only trihexyphenidyl in oral dose form (
780708009) -
Product containing opicapone (
763548009) -
Product containing opicapone in oral dose form (
764317008) -
Product containing pergolide (
108468004) -
Product containing pergolide in oral dose form (
772677006) -
Product containing piribedil (
1173977003) -
Product containing piribedil in oral dose form (
1173979000) -
Product containing pramipexole (
108471007) -
Product containing pramipexole in oral dose form (
768230002) -
Product containing precisely amantadine hydrochloride 10 milligram/1 milliliter conventional release oral solution (
769279001) -
Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral capsule (
323133000) -
Product containing precisely amantadine hydrochloride 100 milligram/1 each conventional release oral tablet (
375373003) -
Product containing precisely apomorphine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (
781768002) -
Product containing precisely apomorphine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (
781767007) -
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral capsule (
323107008) -
Product containing precisely benserazide 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (
784894004) -
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral capsule (
323108003) -
Product containing precisely benserazide 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (
784895003) -
Product containing precisely benserazide 50 milligram and levodopa 200 milligram/1 each conventional release oral capsule (
323109006) -
Product containing precisely benzatropine mesilate 2 milligram/1 each conventional release oral tablet (
323239005) -
Product containing precisely benzatropine mesilate 500 microgram/1 each conventional release oral tablet (
376547002) -
Product containing precisely biperiden hydrochloride 2 milligram/1 each conventional release oral tablet (
323243009) -
Product containing precisely biperiden hydrochloride 4 milligram/1 each prolonged-release oral tablet (
1163233001) -
Product containing precisely biperiden lactate 5 milligram/1 milliliter conventional release solution for injection (
1193678001) -
Product containing precisely bromocriptine (as bromocriptine mesilate) 1 milligram/1 each conventional release oral tablet (
325992007) -
Product containing precisely bromocriptine (as bromocriptine mesilate) 10 milligram/1 each conventional release oral capsule (
325991000) -
Product containing precisely bromocriptine (as bromocriptine mesilate) 2.5 milligram/1 each conventional release oral tablet (
325989008) -
Product containing precisely bromocriptine (as bromocriptine mesilate) 5 milligram/1 each conventional release oral capsule (
325993002) -
Product containing precisely bromocriptine (as bromocriptine mesilate) 800 microgram/1 each conventional release oral tablet (
1153517003) -
Product containing precisely cabergoline 1 milligram/1 each conventional release oral tablet (
323192008) -
Product containing precisely cabergoline 2 milligram/1 each conventional release oral tablet (
323193003) -
Product containing precisely cabergoline 4 milligram/1 each conventional release oral tablet (
323194009) -
Product containing precisely cabergoline 500 microgram/1 each conventional release oral tablet (
326064008) -
Product containing precisely carbidopa 12.5 milligram and entacapone 200 milligram and levodopa 50 milligram/1 each conventional release oral tablet (
410861007) -
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 100 milligram/1 each conventional release oral tablet (
410862000) -
Product containing precisely carbidopa 25 milligram and entacapone 200 milligram and levodopa 200 milligram/1 each conventional release oral tablet (
427802002) -
Product containing precisely carbidopa 25 milligram and levodopa 100 milligram/1 each prolonged-release oral tablet (
1145414000) -
Product containing precisely carbidopa 37.5 milligram and entacapone 200 milligram and levodopa 150 milligram/1 each conventional release oral tablet (
410863005) -
Product containing precisely carbidopa 50 milligram and levodopa 200 milligram/1 each prolonged-release oral tablet (
1145415004) -
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release oral tablet (
1153521005) -
Product containing precisely carbidopa anhydrous (as carbidopa) 10 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (
785958008) -
Product containing precisely carbidopa anhydrous (as carbidopa) 12.5 milligram and levodopa 50 milligram/1 each conventional release oral tablet (
1153523008) -
Product containing precisely carbidopa anhydrous (as carbidopa) 18.75 milligram and entacapone 200 milligram and levodopa 75 milligram/1 each conventional release oral tablet (
785956007) -
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release oral tablet (
1153522003) -
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 100 milligram/1 each conventional release orodispersible tablet (
785959000) -
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release oral tablet (
1153520006) -
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram and levodopa 250 milligram/1 each conventional release orodispersible tablet (
785960005) -
Product containing precisely carbidopa anhydrous (as carbidopa) 25 milligram/1 each conventional release oral tablet (
1153519000) -
Product containing precisely carbidopa anhydrous (as carbidopa) 31.25 milligram and entacapone 200 milligram and levodopa 125 milligram/1 each conventional release oral tablet (
785957003) -
Product containing precisely entacapone 200 milligram/1 each conventional release oral tablet (
323202009) -
Product containing precisely levodopa 500 milligram/1 each conventional release oral tablet (
323095008) -
Product containing precisely lisuride maleate 200 microgram/1 each conventional release oral tablet (
783106003) -
Product containing precisely opicapone 25 milligram/1 each conventional release oral capsule (
897283002) -
Product containing precisely opicapone 50 milligram/1 each conventional release oral capsule (
897284008) -
Product containing precisely orphenadrine citrate 100 milligram/1 each conventional release oral tablet (
376737003) -
Product containing precisely orphenadrine hydrochloride 10 milligram/1 milliliter conventional release oral solution (
769305009) -
Product containing precisely orphenadrine hydrochloride 5 milligram/1 milliliter conventional release oral solution (
323233006) -
Product containing precisely orphenadrine hydrochloride 50 milligram/1 each conventional release oral tablet (
783109005) -
Product containing precisely pergolide (as pergolide mesilate) 1 milligram/1 each conventional release oral tablet (
783624000) -
Product containing precisely pergolide (as pergolide mesilate) 250 microgram/1 each conventional release oral tablet (
783625004) -
Product containing precisely pergolide (as pergolide mesilate) 50 microgram/1 each conventional release oral tablet (
783626003) -
Product containing precisely piribedil 50 milligram/1 each prolonged-release oral tablet (
1173976007) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each conventional release oral tablet (
1179006000) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.05 milligram/1 each prolonged-release oral tablet (
1172374008) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 1.57 milligram/1 each prolonged-release oral tablet (
1177148001) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 180 microgram/1 each conventional release oral tablet (
1177138003) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.1 milligram/1 each prolonged-release oral tablet (
1172376005) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 2.62 milligram/1 each prolonged-release oral tablet (
1177149009) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 260 microgram/1 each prolonged-release oral tablet (
1172378006) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 3.15 milligram/1 each prolonged-release oral tablet (
1172375009) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 350 microgram/1 each conventional release oral tablet (
1177139006) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each conventional release oral tablet (
1177147006) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 520 microgram/1 each prolonged-release oral tablet (
1172377001) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 700 microgram/1 each conventional release oral tablet (
1177141007) -
Product containing precisely pramipexole (as pramipexole dihydrochloride) 88 microgram/1 each conventional release oral tablet (
1177137008) -
Product containing precisely procyclidine hydrochloride 1 milligram/1 milliliter conventional release oral solution (
766587003) -
Product containing precisely procyclidine hydrochloride 5 milligram/1 each conventional release oral tablet (
323256002) -
Product containing precisely procyclidine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (
782078006) -
Product containing precisely procyclidine hydrochloride 500 microgram/1 milliliter conventional release oral solution (
766586007) -
Product containing precisely rasagiline (as rasagiline mesilate) 1 milligram/1 each conventional release oral tablet (
1156150004) -
Product containing precisely rasagiline (as rasagiline mesilate) 500 microgram/1 each conventional release oral tablet (
1156278005) -
Product containing precisely rasagiline (as rasagiline tartrate) 1 milligram/1 each conventional release oral tablet (
1155907003) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 1 milligram/1 each conventional release oral tablet (
323184004) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each conventional release oral tablet (
323185003) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 2 milligram/1 each prolonged-release oral tablet (
437973004) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 250 microgram/1 each conventional release oral tablet (
323183005) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 3 milligram/1 each conventional release oral tablet (
1208572008) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each conventional release oral tablet (
1208571001) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 4 milligram/1 each prolonged-release oral tablet (
437870000) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 5 milligram/1 each conventional release oral tablet (
323186002) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 500 microgram/1 each conventional release oral tablet (
1208573003) -
Product containing precisely ropinirole (as ropinirole hydrochloride) 8 milligram/1 each prolonged-release oral tablet (
438267007) -
Product containing precisely rotigotine 125 microgram/1 hour prolonged-release transdermal patch (
1231482000) -
Product containing precisely rotigotine 166.667 microgram/1 hour prolonged-release transdermal patch (
769520004) -
Product containing precisely rotigotine 250 microgram/1 hour prolonged-release transdermal patch (
769524008) -
Product containing precisely rotigotine 41.667 microgram/1 hour prolonged-release transdermal patch (
1231484004) -
Product containing precisely rotigotine 83.333 microgram/1 hour prolonged-release transdermal patch (
769516003) -
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release oral tablet (
323155008) -
Product containing precisely selegiline hydrochloride 1.25 milligram/1 each conventional release orodispersible tablet (
784588001) -
Product containing precisely selegiline hydrochloride 10 milligram/1 each conventional release oral tablet (
323157000) -
Product containing precisely selegiline hydrochloride 2 milligram/1 milliliter conventional release oral solution (
769276008) -
Product containing precisely selegiline hydrochloride 5 milligram/1 each conventional release oral capsule (
375222008) -
Product containing precisely selegiline hydrochloride 5 milligram/1 each conventional release oral tablet (
323158005) -
Product containing precisely tolcapone 100 milligram/1 each conventional release oral tablet (
375993004) -
Product containing precisely tolcapone 200 milligram/1 each conventional release oral tablet (
376002006) -
Product containing precisely trihexyphenidyl hydrochloride 1 milligram/1 milliliter conventional release oral solution (
769130002) -
Product containing precisely trihexyphenidyl hydrochloride 2 milligram/1 each conventional release oral tablet (
323223003) -
Product containing precisely trihexyphenidyl hydrochloride 5 milligram/1 each conventional release oral tablet (
323224009) -
Product containing procyclidine (
44990002) -
Product containing procyclidine in oral dose form (
430150006) -
Product containing procyclidine in parenteral dose form (
430219003) -
Product containing rasagiline (
419010007) -
Product containing rasagiline in oral dose form (
768166005) -
Product containing ropinirole (
108473005) -
Product containing ropinirole in oral dose form (
768149008) -
Product containing rotigotine (
421915002) -
Product containing rotigotine in transdermal dose form (
769235004) -
Product containing safinamide (
763521008) -
Product containing safinamide in oral dose form (
764153003) -
Product containing selegiline in oral dose form (
768917007) -
Product containing selegiline in oromucosal dose form (
785584008) -
Product containing tolcapone (
108464002) -
Product containing tolcapone in oral dose form (
768777006) -
Product containing trihexyphenidyl (
2190009) -
Product containing trihexyphenidyl in oral dose form (
768027004) -
Profenamine (
52850008) -
Profenamine hydrochloride (
83309005) -
Progressive supranuclear palsy parkinsonism syndrome (
1156764005) -
Psychosis co-occurrent and due to Parkinson's disease (
719717006) -
Rapid onset dystonia parkinsonism (
702323008) -
Rasagiline (
418734001) -
Rasagiline mesilate (
734664007) -
Rasagiline tartrate (
734665008) -
Referral to Parkinson's service (
862081000000106) -
Referral to Parkinson's service (
862091000000108) -
Referral to community Parkinson's disease clinical nurse specialist (
924261000000104) -
Referral to community Parkinson's disease clinical nurse specialist (
924271000000106) -
Referral to community Parkinson's service (
879471000000102) -
Referral to community Parkinson's service (
879481000000100) -
Restrictive lung disease due to Parkinson disease (
103871000119109) -
Ropinirole (
372499000) -
Rotigotine (
421924006) -
Safinamide (
718852000) -
Safinamide mesylate (
1217565003) -
Secondary parkinsonism (
50364008) -
Secondary parkinsonism (
230292008) -
Seen by Parkinson's disease service (
907151000000108) -
Seen by Parkinson's service (
907161000000106) -
Selegiline (
372497003) -
Selegiline adverse reaction (
292409004) -
Selegiline hydrochloride (
108467009) -
Sporadic Parkinson disease (
724761004) -
Sporadic infantile bilateral striatal necrosis (
1010642001) -
Striatonigral degeneration (
29618004) -
Substance with catechol-O-methyltransferase inhibitor mechanism of action (
372646000) -
Substance with dihydroxyphenylalanine decarboxylase inhibitor mechanism of action (
418795002) -
Symptomatic parkinsonism (
265377002) -
Syphilitic parkinsonism (
38523005) -
Tolcapone (
386851002) -
Trihexyphenidyl (
387120000) -
Trihexyphenidyl hydrochloride (
387336005) -
Tropatepine (
734969000) -
Tropatepine hydrochloride (
734970004) -
Type A Wolff-Parkinson-White pattern (
251116002) -
Type B Wolff-Parkinson-White pattern (
251117006) -
Unified Parkinson's Disease Rating Scale total points (
1099221000000108) -
Unified Parkinsons disease rating scale score (
342061000000106) -
Vascular parkinsonism (
230296006) -
Vascular parkinsonism (
707791000000105) -
Wolff-Parkinson-White pattern (
251115003) -
Wolff-Parkinson-White pattern (
74390002) -
X-linked dystonia parkinsonism (
698279003) -
X-linked parkinsonism with spasticity syndrome (
770757004) -
Young onset Parkinson disease (
715345007) -
[X]Accidental poisoning by and exposure to antiparkinson drugs (
221775003) -
[X]Accidental poisoning by and exposure to antiparkinson drugs (
386201000000106) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at home (
221776002) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at home (
474051000000109) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area (
457801000000108) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area (
221782004) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at other specified place (
386851000000108) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at other specified place (
221784003) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area (
221778001) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area (
457811000000105) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area (
221779009) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area (
433771000000103) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area (
457791000000109) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area (
221781006) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place (
474521000000106) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place (
221785002) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence in residential institution (
404311000000103) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence in residential institution (
221777006) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence on farm (
435001000000105) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence on farm (
221783009) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence on street and highway (
221780007) -
[X]Accidental poisoning by and exposure to antiparkinson drugs, occurrence on street and highway (
404331000000106) -
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use (
394321000000104) -
[X]Antiepileptics and antiparkinsonism drugs causing adverse effects in therapeutic use (
223012008) -
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use (
223020005) -
[X]Antiparkinsonism drugs causing adverse effects in therapeutic use (
447011000000104) -
[X]Dementia in Parkinson's disease (
479161000000109) -
[X]Dementia in Parkinson's disease (
192177005) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs (
405241000000105) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs (
222037006) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at home (
405251000000108) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at home (
222038001) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area (
458151000000101) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area (
222044002) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at other specified place (
459391000000102) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at other specified place (
222046000) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area (
393891000000106) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area (
222040006) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area (
222041005) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area (
435541000000101) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area (
458121000000106) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area (
222043008) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place (
222047009) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place (
422331000000108) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence in residential institution (
222039009) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence in residential institution (
434931000000104) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence on farm (
385741000000105) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence on farm (
222045001) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence on street and highway (
404581000000104) -
[X]Intentional self poisoning by and exposure to antiparkinson drugs, occurrence on street and highway (
222042003) -
[X]Other drug-induced secondary parkinsonism (
396511000000105) -
[X]Other drug-induced secondary parkinsonism (
194468007) -
[X]Other secondary parkinsonism (
477761000000101) -
[X]Other secondary parkinsonism (
194469004) -
[X]Parkinsonism in diseases classified elsewhere (
194470003) -
[X]Parkinsonism in diseases classified elsewhere (
477771000000108) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at home, undetermined intent (
423151000000109) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at home, undetermined intent (
222636001) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area, undetermined intent (
222642002) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at industrial and construction area, undetermined intent (
458251000000107) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at other specified place, undetermined intent (
222644001) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at other specified place, undetermined intent (
386091000000105) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area, undetermined intent (
222638000) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at school, other institution and public administrative area, undetermined intent (
386821000000103) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area, undetermined intent (
386831000000101) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at sports and athletics area, undetermined intent (
222639008) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area, undetermined intent (
404661000000107) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at trade and service area, undetermined intent (
222641009) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place, undetermined intent (
422261000000107) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence at unspecified place, undetermined intent (
222645000) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence in residential institution, undetermined intent (
472991000000107) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence in residential institution, undetermined intent (
222637005) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence on farm, undetermined intent (
421381000000104) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence on farm, undetermined intent (
222643007) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence on street and highway, undetermined intent (
406001000000106) -
[X]Poisoning by and exposure to antiparkinson drugs, occurrence on street and highway, undetermined intent (
222640005) -
[X]Poisoning by and exposure to antiparkinson drugs, undetermined intent (
460341000000108) -
[X]Poisoning by and exposure to antiparkinson drugs, undetermined intent (
222635002) -
[X]Poisoning by antiparkinsonism drugs and other central muscle-tone depressants (
429931000000103) -
[X]Poisoning by antiparkinsonism drugs and other central muscle-tone depressants (
213665001) -
[X]Secondary parkinsonism due to other external agents (
194479002) -
[X]Secondary parkinsonism due to other external agents (
412431000000109) -
[X]Secondary parkinsonism due to other external agents (
390141000000101) -
[X]Secondary parkinsonism due to other external agents (
192829007) -
[X]Secondary parkinsonism, unspecified (
471011000000107) -
[X]Secondary parkinsonism, unspecified (
192830002) -
[X]Secondary parkinsonism, unspecified (
456481000000104) -
[X]Secondary parkinsonism, unspecified (
194477000)